This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of pharmaceutical agents targeting neurological disorders. Its structure suggests potential activity as a serotonin receptor modulator, making it a candidate for treating conditions such as depression, anxiety, or migraines. The presence of the benzoyloxy group and the dihydroxybutanedioate moiety enhances its ability to interact with biological targets, improving its pharmacokinetic properties. Researchers may explore its use in designing drugs with improved efficacy and reduced side effects, focusing on optimizing its binding affinity and selectivity for specific receptors. Additionally, its chemical framework could serve as a scaffold for synthesizing analogs to further investigate structure-activity relationships in drug discovery.